Prana Therapeutics is developing targeted therapeutics for the prevention of the negative side effects of chemotherapy, management of rheumatoid arthritis and treatment of brain cancer.
The vast majority of diseases are driven by multiple factors, yet the vast majority of drug development trials use single agents targeting a single contributing mechanism of the disease. Prana Therapeutics’ Polymolecular Botanical Drug development platform addresses these deficiencies by simultaneously targeting multiple mechanisms and de-risking clinical drug development through early stage trials.
Our lead product is a Polymolecular Botanical compound called Epidiferphane, which is a unique composition of matter composed of three botanical extracts with documented synergistic actions.
What is it
Prana Medicinals is 100% plant-based hypoallergenic medicine that targets the Endocannabinoid system with an integrated approach to personalized patient care. Our patented product line offers the widest range of accurately dosed phytocannabinoids and cannabinoids with multiple delivery methods.
How it works
When a patient signs up for our complimentary A.C.T. Now Program they are assigned to a nurse that will assess his/her current medications and creates a personalized program for them. The patients then can rely on a robust HIPAA compliant cloud-based software to record their health conditions, schedule follow ups, and continue to fine tune their programs with their assigned health professional.
Who can benefit from it
New patients exploring the daily benefits of cannabis as a supplement to medical patients managing chronic pain, inflammation, sleep, appetite, glaucoma, migraine, PTSD, neuropathy, multiple sclerosis, fibromyalgia, seizures, epilepsy, paralysis, autoimmune, autism, tumors, HIV/AIDS, and many types of cancer.